The DREAM trial

Lancet. 2006 Dec 9;368(9552):2049; author reply 2050-1. doi: 10.1016/S0140-6736(06)69826-7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / mortality
  • Diabetes Mellitus, Type 2 / prevention & control*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Life Style*
  • Rosiglitazone
  • Thiazolidinediones / therapeutic use

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone